StemRIM (TSE:4599) Beginning Cash Position : 円0 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is StemRIM Beginning Cash Position?

StemRIM's Beginning Cash Position for the quarter that ended in Jan. 2024 was 円0 Mil.

StemRIM's annual Beginning Cash Position declined from Jul. 2021 (円10,675 Mil) to Jul. 2022 (円10,172 Mil) and declined from Jul. 2022 (円10,172 Mil) to Jul. 2023 (円8,880 Mil).

StemRIM Beginning Cash Position Historical Data

The historical data trend for StemRIM's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Beginning Cash Position Chart

StemRIM Annual Data

Trend

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Beginning Cash Position

Get a 7-Day Free Trial

1,843.40

2,496.42

10,675.24

10,172.22

8,880.19

StemRIM Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Beginning Cash Position	Get a 7-Day Free Trial															-	-	-	-	-

StemRIM Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

StemRIM Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of StemRIM's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

StemRIM (TSE:4599) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085

Website

https://www.stemrim.com

StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines